**Centene Corp. Lowers Earnings Forecast Amid Quarterly Loss**
Centene Corp. has revised its annual earnings guidance downward and reported an unexpected quarterly loss, marking another setback for the health insurer as it faces ongoing challenges in its Affordable Care Act (ACA) segment. The company now anticipates adjusted earnings of $1.75 per share for 2025, a significant decrease from its earlier projection of over $7.25 per share. This figure could potentially drop to $1.25 per share, contingent on the performance of Centene’s Medicaid operations.
Earlier this month, Centene withdrew its 2025 guidance, citing escalating risks in its ACA business. Since that announcement, the company’s difficulties appear to have intensified. Initially, Centene estimated that deviations in insurance market trends could impact revenues by $1.8 billion; however, this estimate has now been revised to $2.4 billion based on updated data.
Following the announcement, Centene’s shares plummeted by as much as 16% before the market opened in New York, although they later recovered some losses. The stock has already seen a 56% decline since the beginning of the year, as of Thursday’s close.
The insurer attributed its second-quarter loss to an error in its ACA business, which was also the reason for its earlier guidance withdrawal. Insurers are compensated for covering sicker patients under the ACA, and Centene indicated it would receive less funding than previously anticipated. For the second quarter, the company reported an adjusted loss of 16 cents per share, while analysts had forecasted a profit of 55 cents per share.
“We are disappointed by our second-quarter results, but we have a clear understanding of the trends that have impacted our performance and are working with urgency and focus to restore our earnings trajectory,” stated Sarah London, CEO of Centene, in the earnings report.
In the second quarter, Centene allocated 93% of its premium revenues to medical costs, exceeding the average analyst expectation of 91.6%. Investors typically prefer a lower percentage. The company’s health benefits ratio, which reflects the portion of premium revenues spent on medical expenses, increased from the previous year, primarily due to issues related to ACA revenue.
Additionally, Centene reported rising medical costs in its ACA plans, along with increased expenses in Medicaid, largely driven by behavioral health, home health, and high-cost medications. The company noted that various government programs likely reducing healthcare coverage may lead patients to seek more medical care while they still can, thereby increasing overall medical spending.
**FAQ**
**What led to Centene Corp.’s quarterly loss?**
Centene Corp. experienced a quarterly loss due to a miscalculation in its Affordable Care Act business, resulting in lower-than-expected compensation for covering sicker patients.
